Investment In Innovation Necessary

The Israeli pharmaceutical market is still in favour of patented medicines, despite the presence of one of the world's largest generic drugmakers, Teva Pharmaceuticals . Patented drugs accounted for 54.6% of all pharmaceutical sales in the country and 70% of the prescription drug market. Out-of-pocket spending on medicines and healthcare is increasing, which will in turn increase patients' preferences for cheaper generics.

To read the full article, please choose one of the following options: